Caution on Symbiox Investment
In light of tips being shared on SMS/Whatsapp, recommend caution on Symbiox Investment and Trading. The company's September 2016 (Q2) results showed less than 1 crore income for the quarter (total Rs. 96 lakhs in revenue for the three months ending September 2016) and declining net profits compared to the same quarter last year. Net profits for September Q2 this year was Rs. 83,000, compared to a profit of Rs. 8.6 lakh in the same period last year. Board Meeting Intimation for Results & Closure of Trading Window
Symbiox Investment & Trading Company Ltd has informed BSE that the meeting of Board of Director of the Company is scheduled to be held on February 14, 2017, inter alia, to transact the following Matters:1. Pursuant to Regulation 33 of SEBI (Listing Obligation & Disclosure Requirement) Regulation 2015 consider and approve Un-audited Financial Result for Quarter ended on December 31, 2016.... Shareholding for the Period Ended December 31, 2016
Symbiox Investment & Trading Company Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Symbiox Investment & Trading Company Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Outcome of Board Meeting
Symbiox Investment & Trading Company Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 10, 2016, inter alia, has transacted the following;- Approved as per the Company's Code of Conduct for Prohibition of Insider Trading, the trading window for dealing in the securities of the Company will be closed for the purpose of declaration of Unaudited financial results for the quarter ended on September... Standalone Financial Results, Limited Review Report for September 30, 2016
Symbiox Investment & Trading Company Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Standalone Limited Review for the period ended September 30, 2016 Board Meeting Intimation for Results & Closure of Trading Window
Symbiox Investment & Trading Company Ltd has informed BSE that the meeting of Board of Director of the Company scheduled to be held on November 10, 2016, inter alia, to transact the following Matters:1. Pursuant to Regulation 33 of SEBI (Listing Obligation & Disclosure Requirement) Regulation 2015 consider and approve Un-audited Financial Result for Quarter ended on September 30, 2016.... Shareholding for the Period Ended September 30, 2016
Symbiox Investment & Trading Company Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Symbiox Investment & Trading Company Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Symbiox Investment & Trading Company Ltd has informed BSE regarding the details of Voting results at the 37th Annual General Meeting (AGM) of the Company held on September 30, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer's Report.